RuleCascade is research on how healthcare gets paid: what is changing in policy, reimbursement, and enforcement, and who it moves. When the analysis points to a name cleanly enough to stand behind, I make the call and track it. Most of the work is the analysis.
I publish 10 to 12 times a year, on no set schedule.
Every call is tracked from the first trading session after its evidence was public — the source document's date sets the entry, not the issue date — and graded against XLV, before costs. Nothing is backdated. Wrong calls stay up and get corrected in the open.
None of this is investment advice.